These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 34587481)
61. Complement dysregulation is associated with severe COVID-19 illness. Yu J; Gerber GF; Chen H; Yuan X; Chaturvedi S; Braunstein EM; Brodsky RA Haematologica; 2022 May; 107(5):1095-1105. PubMed ID: 34289657 [TBL] [Abstract][Full Text] [Related]
62. Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome. Sulaiman I; Chung M; Angel L; Tsay JJ; Wu BG; Yeung ST; Krolikowski K; Li Y; Duerr R; Schluger R; Thannickal SA; Koide A; Rafeq S; Barnett C; Postelnicu R; Wang C; Banakis S; Pérez-Pérez L; Shen G; Jour G; Meyn P; Carpenito J; Liu X; Ji K; Collazo D; Labarbiera A; Amoroso N; Brosnahan S; Mukherjee V; Kaufman D; Bakker J; Lubinsky A; Pradhan D; Sterman DH; Weiden M; Heguy A; Evans L; Uyeki TM; Clemente JC; de Wit E; Schmidt AM; Shopsin B; Desvignes L; Wang C; Li H; Zhang B; Forst CV; Koide S; Stapleford KA; Khanna KM; Ghedin E; Segal LN Nat Microbiol; 2021 Oct; 6(10):1245-1258. PubMed ID: 34465900 [TBL] [Abstract][Full Text] [Related]
63. Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19. Rodriguez L; Pekkarinen PT; Lakshmikanth T; Tan Z; Consiglio CR; Pou C; Chen Y; Mugabo CH; Nguyen NA; Nowlan K; Strandin T; Levanov L; Mikes J; Wang J; Kantele A; Hepojoki J; Vapalahti O; Heinonen S; Kekäläinen E; Brodin P Cell Rep Med; 2020 Aug; 1(5):100078. PubMed ID: 32838342 [TBL] [Abstract][Full Text] [Related]
64. Terminal complexes of the complement system: new structural insights and their relevance to function. Morgan BP; Walters D; Serna M; Bubeck D Immunol Rev; 2016 Nov; 274(1):141-151. PubMed ID: 27782334 [TBL] [Abstract][Full Text] [Related]
65. Neurovascular injury with complement activation and inflammation in COVID-19. Lee MH; Perl DP; Steiner J; Pasternack N; Li W; Maric D; Safavi F; Horkayne-Szakaly I; Jones R; Stram MN; Moncur JT; Hefti M; Folkerth RD; Nath A Brain; 2022 Jul; 145(7):2555-2568. PubMed ID: 35788639 [TBL] [Abstract][Full Text] [Related]
67. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases. Wu M; Chen Y; Xia H; Wang C; Tan CY; Cai X; Liu Y; Ji F; Xiong P; Liu R; Guan Y; Duan Y; Kuang D; Xu S; Cai H; Xia Q; Yang D; Wang MW; Chiu IM; Cheng C; Ahern PP; Liu L; Wang G; Surana NK; Xia T; Kasper DL Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28336-28343. PubMed ID: 33082228 [TBL] [Abstract][Full Text] [Related]
68. SARS-CoV2 pneumonia recovery is linked to expansion of innate lymphoid cells type 2 expressing CCR10. Gomes AMC; Farias GB; Dias-Silva M; Laia J; Trombetta AC; Godinho-Santos A; Rosmaninho P; Santos DF; Conceição CM; Costa-Reis R; Adão-Serrano M; Mota C; Almeida ARM; Sousa AE; Fernandes SM Eur J Immunol; 2021 Dec; 51(12):3194-3201. PubMed ID: 34564853 [TBL] [Abstract][Full Text] [Related]
69. Dynamic heterogeneity in COVID-19: Insights from a mathematical model. Voutouri C; Hardin CC; Naranbhai V; Nikmaneshi MR; Khandekar MJ; Gainor JF; Munn LL; Jain RK; Stylianopoulos T PLoS One; 2024; 19(5):e0301780. PubMed ID: 38820409 [TBL] [Abstract][Full Text] [Related]
70. The case of complement inhibitors. Noris M Adv Biol Regul; 2021 Aug; 81():100822. PubMed ID: 34454870 [TBL] [Abstract][Full Text] [Related]
72. The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity. Bolouri H; Speake C; Skibinski D; Long SA; Hocking AM; Campbell DJ; Hamerman JA; Malhotra U; Buckner JH; J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33529167 [TBL] [Abstract][Full Text] [Related]
73. Eye Diseases Direct Interest to Complement Pathway and Macrophages as Regulators of Inflammation in COVID-19. Jager MJ; Seddon JM Asia Pac J Ophthalmol (Phila); 2020 Dec; 10(1):114-120. PubMed ID: 33290288 [TBL] [Abstract][Full Text] [Related]
74. Modelling and analysis of the complement system signalling pathways: roles of C3, C5a and pro-inflammatory cytokines in SARS-CoV-2 infection. Murad D; Zafar Paracha R; Saeed MT; Ahmad J; Mushtaq A; Humayun M PeerJ; 2023; 11():e15794. PubMed ID: 37744234 [TBL] [Abstract][Full Text] [Related]
75. Immune Response Dynamics and Biomarkers in COVID-19 Patients. Ranjbar M; Cusack RP; Whetstone CE; Brister DL; Wattie J; Wiltshire L; Alsaji N; Le Roux J; Cheng E; Srinathan T; Ho T; Sehmi R; O'Byrne PM; Snow-Smith M; Makiya M; Klion AD; Duong M; Gauvreau GM Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928133 [TBL] [Abstract][Full Text] [Related]
76. Tissue Proteomic Analysis Identifies Mechanisms and Stages of Immunopathology in Fatal COVID-19. Russell CD; Valanciute A; Gachanja NN; Stephen J; Penrice-Randal R; Armstrong SD; Clohisey S; Wang B; Al Qsous W; Wallace WA; Oniscu GC; Stevens J; Harrison DJ; Dhaliwal K; Hiscox JA; Baillie JK; Akram AR; Dorward DA; Lucas CD Am J Respir Cell Mol Biol; 2022 Feb; 66(2):196-205. PubMed ID: 34710339 [TBL] [Abstract][Full Text] [Related]
77. SARS-CoV-2 associated Complement genetic variants possibly deregulate the activation of the Alternative pathway affecting the severity of infection. Tsiftsoglou SA Mol Immunol; 2021 Jul; 135():421-425. PubMed ID: 33838929 [No Abstract] [Full Text] [Related]